Trinity Biotech (TRIB) Cash from Financing Activities (2021 - 2024)
Historic Cash from Financing Activities for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to $1.8 million.
- Trinity Biotech's Cash from Financing Activities rose 20220.84% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$4.2 million, marking a year-over-year increase of 4964.35%. This contributed to the annual value of $28.8 million for FY2024, which is 27959.11% up from last year.
- According to the latest figures from Q4 2024, Trinity Biotech's Cash from Financing Activities is $1.8 million, which was up 20220.84% from -$1.8 million recorded in Q4 2023.
- Trinity Biotech's Cash from Financing Activities' 5-year high stood at $1.8 million during Q4 2024, with a 5-year trough of -$3.6 million in Q4 2021.
- Moreover, its 4-year median value for Cash from Financing Activities was -$2.1 million (2022), whereas its average is -$1.7 million.
- Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 248.74% in 2023, then surged by 20220.84% in 2024.
- Over the past 4 years, Trinity Biotech's Cash from Financing Activities (Quarter) stood at -$3.6 million in 2021, then soared by 48.56% to -$1.8 million in 2022, then grew by 4.28% to -$1.8 million in 2023, then surged by 202.21% to $1.8 million in 2024.
- Its Cash from Financing Activities was $1.8 million in Q4 2024, compared to -$1.8 million in Q4 2023 and -$2.4 million in Q3 2023.